AnPac Bio-Medical Science Co., Ltd. (ANPC) Reports Q1 Loss of $0.39
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts ANPC Hot Sheet
Join SI Premium – FREE
AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC) reported Q1 EPS of ($0.39), versus $0.00 reported last year. Revenue for the quarter came in at $1.75 million versus the consensus estimate of $0 .
For earnings history and earnings-related data on AnPac Bio-Medical Science Co., Ltd. (ANPC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Aon CEO warns AI data centers carry insurance risks
- First Northwest Bancorp (FNWB) Misses Q3 EPS by 10c
- Intel (INTC) Tops Q3 EPS by 12c, Guidance Misses
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
